FORT LAUDERDALE, Fla., Nov. 11, 2008 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (NasdaqGM:MAKO - News) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Lazard Capital Markets 5th Annual Healthcare Conference at the St. Regis Hotel in New York City on Tuesday, November 18, 2008 at 5:10 p.m. EST.

The presentation will be webcast live and may be accessed by visiting MAKO's website at http://www.makosurgical.com under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets its advanced robotic-arm solution and implants for minimally invasive orthopedic knee procedures. The MAKO Tactile Guidance System(tm) (TGS(tm)) is a surgeon-interactive tactile platform that incorporates a robotic arm and patient-specific visualization technology and prepares the knee joint for the precise and consistently reproducible insertion and alignment of resurfacing implants through a minimal incision. This FDA-cleared TGS allows surgeons to provide a tissue-sparing, bone resurfacing procedure called MAKOplasty(r) to a large, yet underserved patient-specific population suffering from early- to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than 200 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, haptics, robotics and implants. Additional information can be found at http://www.makosurgical.com.

          MAKO Surgical Corp.
          Investors:
          Susan M. Verde
          954-927-2044 x349
          sverde@makosurgical.com
 
          Westwicke Partners
          Mark Klausner
          443-213-0500
          mark.klausner@westwicke.com